Supplementary Figures 1 and 2 and Supplementary Methods from A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies

Damian J. Green, Nural N. Orgun,Jon C. Jones,Mark D. Hylarides,John M. Pagel,Donald K. Hamlin, D.S. Wilbur,Yukang Lin,Darrell R. Fisher,Aimee L. Kenoyer,Shani L. Frayo,Ajay K. Gopal,Johnnie J. Orozco,Theodore A. Gooley,Brent L. Wood,William I. Bensinger,Oliver W. Press

crossref（2023）

引用 0|浏览0

暂无评分

摘要

PDF - 156K, Supplementary Figure 1, demonstrating CD38 receptor surface stability. Supplementary Figure 2, demonstrating animal body weight following anti-CD38 pretargeted radioimmunotherapy. Supplemental methods describing fusion protein construction as well as endocytosis and trichloroacetic acid (TCA) precipitation assays.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要